← Leaderboards
Eric Dumonteil
Tulane University Of Louisiana
$2,593,873
Attributed
$2,593,873
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $943.8K · FY2007–25$1M$750K$500K$250K$0
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$2,593,873 · 4
By mechanism
R01$2,145,891 · 1
R21$420,125 · 1
P51$27,857 · 2
Top collaborators
No co-investigators on record.
Most similar at Tulane University Of Louisiana
Same institution · by research overlap
- Mahesh Mohan$12,801,428
- Angela M Amedee$2,356,313
- Joseph Christopher Mudd$5,625,443
- Elizabeth Schmidt Didier$8,050,961
- Bapi Pahar$4,126,054
Others in their field
Top investigators on “Infection”
- Wafaa M. El-Sadr · Columbia University Health Sciences$965,939,185
- Lawrence Corey · Fred Hutchinson Cancer Center$789,608,171
- Judith S. Currier · University Of California Los Angeles$511,038,212
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$463,711,983
- Richard Marlink · Elizabeth Glaser Pediatric Aids Fdn$457,210,249
- Joseph J. Eron · Univ Of North Carolina Chapel Hill$415,229,497
Research focus
InfectionBloodParasitesChagas DiseaseChronic PhaseCessation Of LifeMacaca MulattaPeripheral Blood Mononuclear CellIn VitroDisease ProgressionMonitorTrypanosoma CruziBiological MarkersAmericasFollow-UpGene Expression ProfileHeart FunctionNonhuman PrimateMacacaChronicEconomicsLifeElectrocardiogramChagasic Cardiomyopathy
Grant awards (7)
Non-inferiority trial of a therapeutic vaccine against Chagas disease in naturally-infected rhesus macaques$679,990
R01 · FY2025 · AI · contact PI
Non-inferiority trial of a therapeutic vaccine against Chagas disease in naturally-infected rhesus macaques$714,298
R01 · FY2024 · AI · contact PI
Intra-host Trypanosoma cruzi parasite dynamics in naturally-infected macaques and Chagas disease progression$229,500
R21 · FY2024 · AI · contact PI
Non-inferiority trial of a therapeutic vaccine against Chagas disease in naturally-infected rhesus macaques$751,603
R01 · FY2023 · AI · contact PI
Intra-host Trypanosoma cruzi parasite dynamics in naturally-infected macaques and Chagas disease progression$190,625
R21 · FY2023 · AI · contact PI
A THERAPEUTIC DNA VACCINE IN NONHUMAN PRIMATE AGAINST CHAGAS DISEASE$13,897
P51 · FY2008 · RR · contact PI
A THERAPEUTIC DNA VACCINE IN NONHUMAN PRIMATE AGAINST CHAGAS DISEASE$13,960
P51 · FY2007 · RR · contact PI